KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Other Working Capital Changes (2017 - 2026)

Aquestive Therapeutics has reported Other Working Capital Changes over the past 9 years, most recently at -$399000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 130.55% year-over-year to -$399000.0; the TTM value through Dec 2025 reached -$1.7 million, down 840.81%, while the annual FY2025 figure was -$698000.0, 413.0% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$399000.0 at Aquestive Therapeutics, up from -$1.2 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $4.0 million in Q2 2023 and troughed at -$5.4 million in Q3 2023.
  • A 5-year average of -$268800.0 and a median of $241500.0 in 2022 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: crashed 1711.64% in 2023 and later skyrocketed 1889.04% in 2024.
  • Year by year, Other Working Capital Changes stood at $535000.0 in 2021, then soared by 33.08% to $712000.0 in 2022, then tumbled by 110.25% to -$73000.0 in 2023, then skyrocketed by 1889.04% to $1.3 million in 2024, then tumbled by 130.55% to -$399000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for AQST at -$399000.0 in Q4 2025, -$1.2 million in Q3 2025, and $397000.0 in Q2 2025.